CRL vs DEA · rev $2.00B vs P/E 54, rev $184.0M
Charles River Laboratories (CRL) versus Eerly Govt Ppty Inc (DEA) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Eerly Govt Ppty Inc (DEA) is a reit - office company listed on US.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported DEA revenue for 2026-06-30 was $184.0M. Net income was $4.4M. DEA currently screens at market cap $1.12B and trailing P/E 54.5.
CRL currently screens at market cap $7.78B. DEA currently screens at market cap $1.12B and trailing P/E 54.5.
Not investment advice. Open the CRL and DEA stock pages for the full models.
Not investment advice.